Stay updated on Pembrolizumab Combined with Azacitidine in Colorectal Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combined with Azacitidine in Colorectal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combined with Azacitidine in Colorectal Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The NIH banner announcing a terminology transition and linking to updates and FAQs has been removed. The page continues to display a 403 error.
    Difference
    1%
    Check dated 2026-11-08T13:44:16.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden response.
    Difference
    0.2%
    Check dated 2026-11-01T14:49:54.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to transition updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T14:00:18.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T14:23:10.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changes from v3.7.0 to v3.7.1. The page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-11T14:59:12.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error and related boilerplate content, replacing the usual study record details with an access-restricted message. This indicates a page access issue rather than an update to study information.
    Difference
    18%
    Check dated 2026-09-20T08:47:56.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combined with Azacitidine in Colorectal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combined with Azacitidine in Colorectal Cancer Clinical Trial page.